acenocoumarol and Coronary-Thrombosis

acenocoumarol has been researched along with Coronary-Thrombosis* in 2 studies

Other Studies

2 other study(ies) available for acenocoumarol and Coronary-Thrombosis

ArticleYear
[Severe, thromboembolic pulmonary hypertension with recurrent pulmonary embolism and right heart thrombi in a patient with past myocardial infarction, cerebral ischaemic stroke and small intestine necrosis].
    Kardiologia polska, 2011, Volume: 69, Issue:1

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a chronic progressive disease of pulmonary circulation characterised by indistinct ethiopathogenesis. We present a case of a 50 year-old male with thrombophilia of unknown origin leading to the formation of multiple thrombi within venous circulation followed by episodes of acute pulmonary embolism resulting ultimately in acute heart failure in the course of developing CTEPH. Unfortunately, despite the wide range of haemostasis laboratory tests we were not able to define the type of coagulation abnormality. Owing to the efficient cooperation between cardiologists and cardiosurgeons it was possible to save patient's life.

    Topics: Acenocoumarol; Anticoagulants; Cardiac Surgical Procedures; Coronary Thrombosis; Echocardiography, Doppler; Humans; Hypertension, Pulmonary; Intestine, Small; Male; Middle Aged; Myocardial Infarction; Necrosis; Pulmonary Embolism; Stroke; Time Factors; Treatment Outcome; Warfarin

2011
[Left coronary artery embolism resulting from ineffective anticoagulation in a patient suffering from dilated cardiomyopathy as a possible cause of myocardial infarction--a case report].
    Kardiologia polska, 2007, Volume: 65, Issue:6

    We present a case of a 58-year-old male being treated for dilated cardiomyopathy and atrial fibrillation for more than ten years who was admitted to the intensive care unit with the diagnosis of acute ST-segment elevation myocardial infarction (STEMI). In course of further diagnostics the coronary artery embolism resulting from the unintentional anticoagulant drug (acenocumarol) dose reduction was established as the most probable cause of STEMI. Primary percutaneous coronary intervention was successfully performed and the patient was discharged home in good clinical condition.

    Topics: Acenocoumarol; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiomyopathy, Dilated; Coronary Angiography; Coronary Thrombosis; Electrocardiography; Heart Conduction System; Humans; Male; Middle Aged; Myocardial Infarction; Treatment Outcome

2007